Due to the inactivation of OTUB1 deubiquitination, ZnCM NPs promoted CCL5 degradation via NF-κB signalling to induce tDCs for further T-cell response inhibition, resulting in a repressed interaction between splenic CD11+ DCs and CD4+ T cells to inhibit RA progression. This evidence concerns the gene CCL5 and rheumatoid arthritis.